Fremanezumab Completed Phase 3 Trials for prophylaxis of migraine headaches Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03308968An Efficacy and Safety Study of Fremanezumab in Adults With Migraine